PCN28 COST-UTILITY ANALYSIS IN A SPANISH SETTING OF ADJUVANT THERAPY WITH TRASTUZUMAB (HERCEPTIN®) IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER
C Polanco, M Carulla, X Badia, A Ramirez-ArellanoVolume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)66565-5
File:
PDF, 78 KB
english, 2008